Dermatol. praxi. 2020;14(3):157-159 | DOI: 10.36290/der.2020.030

Desmoid tumor (deep fibromatosis) of the forearm

MUDr. PhDr. Vladimír Bartoš, PhD., MPH
Martinské bioptické centrum, s. r. o., Martin

The author describes a case report of a 56-year old woman, who observed a subcutaneous tumor lesion arising in the left forearm. It clinically appeared as a lipoma. A surgical extirpation of adipose tissue was done, in which a compact tumor mass was identified. It was whitish in color and firm in consistency. Histologically, it consisted of proliferating bland spindle-shaped (myo)fibroblasts with slightly increased mitotic activity. The neoplastic cells were immunohistochemically positive for Faktor XIIIa, α-SMA and calponin and displayed a nuclear reactivity for β-catenin. The tumor margins showed an infiltrative growth pattern. Based on histopathology and immunophenotype, a diagnosis of deep fibromatosis (desmoid tumor) was established. Desmoid tumors of subcutaneous soft tissue are rarely encountered in dermatopathological practice. Although without metastatic potential, they grow aggressively and are accompanied by frequent local recurrences (about 40 % of cases). Therefore, after surgical removal of the tumor, further clinical follow-up of patient is necessary.

Keywords: deep fibromatosis, desmoid tumor, soft tissue tumors.

Published: October 20, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bartoš V. Desmoid tumor (deep fibromatosis) of the forearm. Dermatol. praxi. 2020;14(3):157-159. doi: 10.36290/der.2020.030.
Download citation

References

  1. Weiss SW, Goldblum JR (Eds). Enzinger and Weisss Soft Tissue Tumors. 4th edition. Mosby, Inc. 2001.
  2. Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F (Eds). WHO Classification of Tumours of Soft Tissue and Bone. IARC: Lyon 2013.
  3. Zreik RT, Fritchie KJ. Morphologic spectrum of desmoid‑type fibromatosis. Am J Clin Pathol 2016; 145(3): 332-340. Go to original source... Go to PubMed...
  4. Escobar C, Munker R, Thomas JO, Li BD, Burton GV. Update on desmoid tumors. Ann Oncol 2012; 23(3): 562-569. Go to original source... Go to PubMed...
  5. Lips DJ, Barker N, Clevers H, Hennipman A. The role of APC and beta‑catenin in the aetiology of aggressive fibromatosis (desmoid tumors). Eur J Surg Oncol 2009; 35(1): 3-10. Go to original source... Go to PubMed...
  6. Kransdorf MJ, Murphey MD. Imaging of Soft Tissue Tumors. 2nd edition. Philadelphia: Lippincott, Williams & Wilkins. 2006.
  7. Lazar AJ, Tuvin D, Hajibashi S, et al. Specific mutations in the beta‑catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. Am J Pathol 2008; 173(5): 1518-1527. Go to original source... Go to PubMed...
  8. Bhattacharya B, Dilworth HP, Iacobuzio‑Donahue C, et al. Nuclear beta‑catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions. Am J Surg Pathol 2005; 29(5): 653-659. Go to original source... Go to PubMed...
  9. Carlson JW, Fletcher CD. Immunohistochemistry for beta‑catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature. Histopathology 2007; 51(4): 509-514 Go to original source... Go to PubMed...
  10. Sakai T, Nishida Y, Hamada S, et al. Immunohistochemical staining with non‑phospho β‑catenin as a diagnostic and prognostic tool of COX-2 inhibitor therapy for patients with extra‑peritoneal desmoid‑type fibromatosis. Diagn Pathol 2017; 12(1): 66. Go to original source... Go to PubMed...




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.